The Perils of Confusing Drug Brand Names The Perils of Confusing Drug Brand Names

The Perils of Confusing Drug Brand Names

by Peter Smith

May 14, 2011

Lipitor is one of the county's top-selling drugs and the patented statin is designed to treat the symptoms of our often unhealthy diets—it lowers cholesterol levels.

Greg Warner, of Marketplace's Health Desk, recently looked into the fascinating name game that goes into drug marketing, which can make the difference between a successful drug and an outright failure. Part of what makes a successful drug brand name comes down to its sound and associations. Just as phonetic-sounding names can play a role in branding and selling foods or altering our perception of flavor, a name like Celebrex carries pretty obvious positive connotations.

Unlike foods, though, the Food and Drug Administration gets final approval of any drug's name and, when it comes down to medicine, confusing two similar-sounding products can have deadlier consequences, as pharmacist Susan Proulx explains in this video. And similar looking drug names can be a problem, too. A doctor's bad handwriting can result in a patient getting meds for allergies instead of cholesterol—or even worse mix-ups.

Recently on GOOD
Sign up to receive the best of GOOD delivered to your inbox each and every weekday
Click for your chance to win a cruise and do some volunteering in the Dominican Republic!
The Perils of Confusing Drug Brand Names